2vti
From Proteopedia
Line 1: | Line 1: | ||
- | + | {{Seed}} | |
+ | [[Image:2vti.jpg|left|200px]] | ||
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_2vti", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_2vti| PDB=2vti | SCENE= }} | ||
- | + | ===IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.=== | |
- | Description: Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ==About this Structure== |
+ | 2VTI is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VTI OCA]. | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Single protein]] | ||
+ | [[Category: Berdini, V.]] | ||
+ | [[Category: Boulstridge, J A.]] | ||
+ | [[Category: Brien, M A.O.]] | ||
+ | [[Category: Carr, M G.]] | ||
+ | [[Category: Cross, D M.]] | ||
+ | [[Category: Danillon, D.]] | ||
+ | [[Category: Davis, D J.]] | ||
+ | [[Category: Devine, L A.]] | ||
+ | [[Category: Early, T R.]] | ||
+ | [[Category: Feltell, R E.]] | ||
+ | [[Category: Lewis, E J.]] | ||
+ | [[Category: Mcmenamin, R L.]] | ||
+ | [[Category: Navarro, E F.]] | ||
+ | [[Category: Reilly, M O.]] | ||
+ | [[Category: Reule, M.]] | ||
+ | [[Category: Saxty, G.]] | ||
+ | [[Category: Seavers, L C.A.]] | ||
+ | [[Category: Smith, D M.]] | ||
+ | [[Category: Squires, M S.]] | ||
+ | [[Category: Trewartha, G.]] | ||
+ | [[Category: Walker, M T.]] | ||
+ | [[Category: Woodhead, A J.]] | ||
+ | [[Category: Woolford, A J.A.]] | ||
+ | [[Category: Wyatt, P G.]] | ||
+ | [[Category: Atp-binding]] | ||
+ | [[Category: Cell cycle]] | ||
+ | [[Category: Cell division]] | ||
+ | [[Category: Fragment screening]] | ||
+ | [[Category: Kinase]] | ||
+ | [[Category: Mitosis]] | ||
+ | [[Category: Nucleotide-binding]] | ||
+ | [[Category: Phosphoprotein]] | ||
+ | [[Category: Phosphorylation]] | ||
+ | [[Category: Polymorphism]] | ||
+ | [[Category: Protein kinase]] | ||
+ | [[Category: Serine/threonine protein kinase]] | ||
+ | [[Category: Serine/threonine-protein kinase]] | ||
+ | [[Category: Structure based drug design]] | ||
+ | [[Category: Transferase]] | ||
+ | |||
+ | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Aug 6 12:50:24 2008'' |
Revision as of 09:50, 6 August 2008
IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
About this Structure
2VTI is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Page seeded by OCA on Wed Aug 6 12:50:24 2008
Categories: Homo sapiens | Single protein | Berdini, V. | Boulstridge, J A. | Brien, M A.O. | Carr, M G. | Cross, D M. | Danillon, D. | Davis, D J. | Devine, L A. | Early, T R. | Feltell, R E. | Lewis, E J. | Mcmenamin, R L. | Navarro, E F. | Reilly, M O. | Reule, M. | Saxty, G. | Seavers, L C.A. | Smith, D M. | Squires, M S. | Trewartha, G. | Walker, M T. | Woodhead, A J. | Woolford, A J.A. | Wyatt, P G. | Atp-binding | Cell cycle | Cell division | Fragment screening | Kinase | Mitosis | Nucleotide-binding | Phosphoprotein | Phosphorylation | Polymorphism | Protein kinase | Serine/threonine protein kinase | Serine/threonine-protein kinase | Structure based drug design | Transferase